Product Pipeline

(As of June 2024)

Development Pipelines

Product code Target Indication Dosage Form Development region Current Phase
M5250 Pruritus with atopic dermatitis (pediatric) Injection JP March, 2024
Approval
M5250B Prurigo nodularis Injection JP March, 2024
Approval
M5250E Pruritus with atopic dermatitis
(infant)
Injection JP PIII
M6050C Acne vulgaris Topical JP PIII
M6100 Atopic dermatitis Topical JP PIII
M6050F Axillary osmidrosis Topical JP PII